RxSight, Inc. (RXST) stock

RXSTNasdaqOphthalmic GoodsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3074% below fair value

$5.32−0.06 (-1.12%)

Close on Nov 13, 2026Market cap $221.28MP/E –Yield –

RxSight profit margin

Profit margin (net margin) is net income as a percentage of revenue.

RxSight's profit margin for the twelve months ending Jun 30, 2026 was -36.8%. For fiscal 2025 it was -29.0%, against -19.6% the year before. The highest annual figure on record is 187.9% in fiscal 2020.

Annual profit margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-29.0%	−9.3
FY2024	Dec 31, 2024	-19.6%	+34.9
FY2023	Dec 31, 2023	-54.6%	+81.7
FY2022	Dec 31, 2022	-136.2%	+79.3
FY2021	Dec 31, 2021	-215.5%	−403.4
FY2020	Dec 31, 2020	187.9%	–

Quarterly profit margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q2 FY2026	Jun 30, 2026	-35.9%	−0.8
Q1 FY2026	Mar 31, 2026	-51.4%	−29.8
Q4 FY2025	Dec 31, 2025	-28.1%	−13.3
Q3 FY2025	Sep 30, 2025	-32.4%	−14.4
Q2 FY2025	Jun 30, 2025	-35.0%	−17.6
Q1 FY2025	Mar 31, 2025	-21.6%	+9.2
Q4 FY2024	Dec 31, 2024	-14.8%	+17.3
Q3 FY2024	Sep 30, 2024	-17.9%	+38.0
Q2 FY2024	Jun 30, 2024	-17.4%	+48.9
Q1 FY2024	Mar 31, 2024	-30.8%	+44.7
Q4 FY2023	Dec 31, 2023	-32.1%	+64.9
Q3 FY2023	Sep 30, 2023	-55.9%	+77.4
Q2 FY2023	Jun 30, 2023	-66.3%	+81.0
Q1 FY2023	Mar 31, 2023	-75.5%	+121.2
Q4 FY2022	Dec 31, 2022	-97.0%	+89.7
Q3 FY2022	Sep 30, 2022	-133.3%	+85.7
Q2 FY2022	Jun 30, 2022	-147.3%	+127.9
Q1 FY2022	Mar 31, 2022	-196.8%	−1.5
Q4 FY2021	Dec 31, 2021	-186.7%	−721.8
Q3 FY2021	Sep 30, 2021	-219.0%	−954.4
Q2 FY2021	Jun 30, 2021	-275.2%	+200.8
Q1 FY2021	Mar 31, 2021	-195.3%	–
Q4 FY2020	Dec 31, 2020	535.1%	–
Q3 FY2020	Sep 30, 2020	735.3%	–
Q2 FY2020	Jun 30, 2020	-476.1%	–